Skip to main navigation

Overview
News & Events
- News Releases
- Events & Presentations
Governance
Financials
- SEC Filings
- IRS Form 8937
Stock
Resources

News Releases

Year

30 May '24

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

16 May '24

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

09 May '24

Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

08 May '24

Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024

06 May '24

Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference

02 May '24

Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer

24 Apr '24

Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

22 Apr '24

Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

03 Apr '24

Carisma Therapeutics to Present at Upcoming Conferences

01 Apr '24

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 23

Site - Investor Tools

Print Page
Email Alerts
RSS Feeds
IR Contact

Request Email Alerts

© 2024 Carisma Therapeutics Inc. All rights reserved.